Example: Heart Attack

Clinical Trials on Teratogenesis

Total 11 results

NCT01624155

Completed

Increasing Contraception Utilization Among Women Prescribed Teratogenic Medications

Conditions: Teratogenesis
NCT04043572

Recruiting

The Biomarkers of Neurological Disease in Utero Study

Conditions: Epilepsy; Neurodevelopmental Disorders; Fetal Disease; Teratogenesis
NCT00404989

Recruiting

Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.

Conditions: HIV Infections; Hepatitis B
NCT03317522

Completed

Maternal Lipids and Offspring Adiposity at 5-7 Years

Conditions: Adiposity
NCT00140179

Completed

Valnoctamide in Mania

Conditions: Mania; Schizoaffective Disorder, Manic Type
NCT03619590

Completed

Twinrix Pregnancy Registry

Conditions: Hepatitis
NCT02921802

Active, not recruiting

A Study of Special Use Results Surveillance of Revlimid 5mg Capsules

Conditions: Multiple Myeloma; Myelodysplastic Syndromes
NCT03098589

Recruiting

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Conditions: Lymphoma
NCT02922543

Active, not recruiting

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

Conditions: Multiple Myeloma
NCT02921828

Active, not recruiting

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Conditions: Multiple Myeloma
NCT00005660

Completed

The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases

Conditions: Basal Cell Carcinoma; Keratosis Palmaris et Plantaris; Psoriasis